Emerging evidence suggests additional targets for miR-23b-3p in non-cancerous diseases, such as neuropilin 1 (Xia et al., 2020), apoptotic protease activating factor-1 (Apaf-1) (Chen et al., 2014), α-synuclein (Geng et al., 2023), and phosphatase and tensin homolog (PTEN) (Guo et al., 2022). Here, PTEN is linked to glycogen storage disease VI.